Takeda Pharmaceutical Co. Ltd. - Cash and Equivalents

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Cash-and-Equivalents" stands at 681.49 Billion Japanese Yens as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Cash and Equivalents" stands at 681.49 Billion JPY. This represents an increase of 94.71 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -20.67 percent compared to the value the year prior.
The 1 year change in percent is -20.67.
The 3 year change in percent is -14.62.
The 5 year change in percent is 8.02.
The 10 year change in percent is 12.03.

The Serie's long term average value is 487.49 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 39.79 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2011, to it's latest available value, on 09/30/2025, is +256.30%.
The Serie's change in percent from it's maximum value, on 03/31/2021, to it's latest available value, on 09/30/2025, is -29.47%.